Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea

The Korean journal of hepatology

Volumn 15, Issue 1, 2009, Pages 25-41

  Kim, Byung Kook ^a   Kwon, So Young ^a   Lee, Chang Hong ^a   Choe, Won Hyeok ^a   Choi, Hong Mi ^a   Koo, Hye Won ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ADENINE; ALPHA INTERFERON; ANTIVIRUS AGENT; DRUG DERIVATIVE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PHOSPHONIC ACID DERIVATIVE;

ARTICLE; BLOOD; COHORT ANALYSIS; COST BENEFIT ANALYSIS; DRUG COMBINATION; ECONOMICS; HEPATITIS B; HOSPITALIZATION; HUMAN; KOREA; QUALITY OF LIFE; STATISTICAL MODEL;

ADENINE; ANTIVIRAL AGENTS; COHORT STUDIES; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; KOREA; LAMIVUDINE; MODELS, STATISTICAL; PHOSPHONIC ACIDS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 67849085492     PISSN: 1738222X     EISSN: None     Source Type: Journal    
DOI: 10.3350/kjhep.2009.15.1.25     Document Type: Article

References (0)